ISPOR Stands With Ukraine

Published Mar 2, 2022

Lawrenceville, NJ, USA—March 2, 2022—As a scientific and educational nonprofit and the leading professional society for health economics and outcomes research globally, ISPOR rarely comments on issues not directly related to healthcare. The unprecedented military attack on Ukraine, however, requires a Society response.

As we witness the horrific events unfolding in Ukraine, we are reminded of the importance of freedom of thought, independence, diversity, and collaboration—not simply as the foundation for science, but more importantly as the basis for human interaction. As a global scientific society, ISPOR condemns the aggression taking place in Ukraine. Our thoughts and prayers for strength are with the Ukrainian people during this dark time. ISPOR extends its support to our affected colleagues who are both important members of the global scientific community and our family.

ISPOR’s mission is to promote health economics and outcomes research excellence to improve decision making for health globally. It goes without saying that an unprovoked war on a democratic country impacts our Society’s commitment to global health. As we stand with Ukraine and our dear friends and colleagues in the region, we find comfort in a quote by Louis Pasteur, “Science and peace will triumph over ignorance and war.”

Those interested in resources to support and donate to the relief efforts may read about options below. ISPOR members can find resources to local outlets for donations on this Member Community.

###

 

Resources for Ukraine Support and Donations:

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×